Machine learning is reshaping the way portfolios are built, monitored, and adjusted. Investors are no longer limited to ...

Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the publication of its peer-reviewed study in Xenobiotica, ‘Predicting routes of phase I and II ...

Laboratory-based design verification testing (DVT) of combination products and medical devices must be performed to demonstrate that the device meets the performance requirements that were set in the ...